Breaking News

Kiniksa Pharmaceuticals Ltd (KNSA)

NASDAQ

Add to/Remove from Watchlist Add to Watchlist

15.10 +0.49 +3.35%

15:10:04 - Real-time Cboe. Currency in USD ( Disclaimer )

Type: Equity

Market: United States

Volume: 320,250
Bid/Ask: 0.00 / 0.00
Day's Range: 14.30 - 15.14

KNSA Cash Flow Statement

Featured here, the Cash Flow Statement for Kiniksa Pharmaceuticals Ltd, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).

Annual Quarterly

Advanced Cash Flow Statement

Collapse All

Period Ending:

2023

31/03

2022

31/12

2022

30/09

2022

30/06

Period Length:

0 Months

Net Income/Starting Line

-12.27

4.46

224.09

-19.98

Cash From Operating Activities

-4.27

-11.58

62.05

-7.82

Depreciation/Depletion	0.596	0.602	0.493	0.651
Amortization	-	-	-	-
Deferred Taxes	1.08	0.348	-185.84	-
Non-Cash Items	7.15	7.32	-179.16	7.53
Cash Receipts	-	-	-	-
Cash Payments	-	-	-	-
Cash Taxes Paid	3.2	6.08	1.32	3.29
Cash Interest Paid	-	-	-	-
Changes in Working Capital	0.26	-23.95	16.63	3.97

Cash From Investing Activities

-37.92

-42.66

19.04

38.26

Capital Expenditures	-0.024	0.032	-0.022	-0.115
Other Investing Cash Flow Items, Total	-37.9	-42.69	19.06	38.38

Cash From Financing Activities

0.09

1.19

0.361

0.542

Financing Cash Flow Items	-	-	-	-
Total Cash Dividends Paid	-	-	-	-
Issuance (Retirement) of Stock, Net	0.09	1.19	0.361	0.542
Issuance (Retirement) of Debt, Net	-	-	-	-

Foreign Exchange Effects

Net Change in Cash

-42.1

-53.05

81.45

30.98

Beginning Cash Balance

122.72

175.76

94.31

63.32

Ending Cash Balance

80.62

122.72

175.76

94.31

Free Cash Flow

-2.52

-10.32

49.17

-0.278

Free Cash Flow Growth

75.53

-120.98

17786.74

99.33

Free Cash Flow Yield

-0.572

-1.11

6.96

-1.18

* In Millions of (except for per share items)

Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

KNSA Comments

Write your thoughts about Kiniksa Pharmaceuticals Ltd

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Stephen Appiah Mar 19, 2021 9:28AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

I'm surprised no activity there is little activity on this stock.

1 0

Report

ArlN Mar 18, 2021 5:15PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

The FDA has approved. - ARCALYST is the first and only FDA-approved therapy for recurrent pericarditis- Commercial launch expected in April 2021- Kiniksa launches Kiniksa One Connect™ patient support program

0 0

Report

ArlN Mar 15, 2021 6:26PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Breakthrough Therapy designation granted by the FDA for rilonacept for the treatment of recurrent pericarditis, due date is 21st March 2021 under priority review.That should help some movement

0 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="221833712">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="221833712" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="221833712" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="221833712">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	33,582.8	-180.0	-0.53%
US 500	4,268.6	-13.8	-0.32%
Dow Jones	33,585.10	-177.66	-0.53%
S&P 500	4,268.70	-13.67	-0.32%
Nasdaq	13,195.72	-45.05	-0.34%
S&P 500 VIX	15.13	+0.53	+3.63%
Dollar Index	103.940	-0.012	-0.01%

Crude Oil WTI	72.02	+0.28	+0.39%
Brent Oil	76.55	+0.42	+0.55%
Natural Gas	2.245	+0.073	+3.36%
Gold	1,978.15	+8.55	+0.43%
Silver	23.657	-0.090	-0.38%
Copper	3.7610	+0.0335	+0.90%
US Soybeans	1,349.00	-4.00	-0.30%

U.S. 10Y	3.687	-0.008	-0.22%
U.S. 30Y	3.880	-0.002	-0.05%
U.S. 5Y	3.826	-0.016	-0.41%
U.S. 3M	5.322	-0.071	-1.32%
US 10Y T-Note	113.88	+0.03	+0.03%
Euro Bund	134.06	-0.86	-0.64%
10-2 Yield Spread	-81.50	-7.10	9.54%

Apple	178.34	-2.61	-1.44%
Alphabet A	125.74	+1.07	+0.86%
Tesla	215.41	+1.45	+0.68%
Amazon.com	124.73	+0.48	+0.39%
Netflix	402.17	+1.70	+0.42%
Meta Platforms	270.61	-2.00	-0.73%
Bank of America	28.58	-0.13	-0.46%

Recent Quotes

	Name	Price	Chg.	Chg. %
	KNSA	15.10	+0.49	+3.35%

Market Movers

Name	Last	Chg. %	Vol.
TSLA	215.42	+0.68%	132.64M
AAPL	178.35	-1.44%	97.23M
AMD	118.19	+0.28%	43.81M
AMZN	124.76	+0.41%	35.25M
NVDA	389.35	-1.00%	32.08M
META	270.50	-0.78%	16.66M
MSFT	336.50	+0.33%	14.24M

Name	Last	Chg. %	Vol.
PANW	227.21	+4.59%	11.35M
BBWI	39.39	+4.46%	2.56M
FTNT	70.86	+4.00%	6.93M
PAYC	304.96	+3.97%	481.69K
ZS	147.40	+3.52%	3.00M
ZM	68.98	+2.82%	6.88M
INTU	442.16	+2.71%	1.34M

Name	Last	Chg. %	Vol.
EPAM	204.25	-21.34%	1.99M
CHRW	91.48	-6.33%	1.93M
GFS	56.55	-4.43%	964.28K
INTC	29.96	-4.30%	31.14M
MMM	98.35	-4.08%	4.91M
DG	159.35	-4.08%	4.81M
MRVL	57.73	-4.07%	11.89M